Claseprubart
Based on 1 Customer Validation
Claseprubart (DNTH103) is an inhibitor targeting C1s of the complement system and an inhibitor of the C1 component of the complement cascade. Claseprubart is in phase 2 clinical evaluation. Claseprubart has application potential in research related to multifocal motor neuropathy and generalized myasthenia gravis.
For research use only. We do not sell to patients.
- Purity: 99%
- CAS No.: 2922766-89-8
- Molecular Weight:144.638 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG4 kappa
Human
Complement C1s
Co-incubation of DNTH103 (0.1 μM, 1 μM) with complement-containing serum from AChR-positive myasthenia gravis patients significantly reduces the muscle contraction fatigue index and improves neuromuscular transmission function in a human iPSC-derived motor neuron-muscle cell co-culture myasthenia gravis model. Its efficacy is superior to that of anti-C5 antibody at the same concentration, and it exerts no significant effect on serum samples from healthy individuals[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
IgG4-kappa
ELISA, FACS, Functional assay
-
Loaded Claseprubart on ProA biosensor, can bind HY-P700696 C1s/Complement C1s Protein, Human (HEK293, His) with an affinity constant of 3.648E-09 M as determined in BLI assay.
Chemical Information
-
CAS No. 2922766-89-8
-
Appearance Liquid
-
Molecular Weight 144.638 kDa
-
Color Colorless to light yellow
-
SMILES
[Claseprubart]
-
Synonyms
DNTH103
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (258 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)